谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

LBA62 Durvalumab after Radiotherapy (RT) in Patients with Unresectable Stage III NSCLC Ineligible for Chemotherapy (CT): Primary Results from the DUART Study

A.R.R. Filippi,M.R. García-Campelo,J Paoli, Diane Kowalski,C. Bennati,P. Borghetti,Diego Cortinovis,Angelo Delmonte,C. Genova, S. van Hülst, R. Mroz,Sergiusz Nawrocki, I. Toledano, G. Tonini,I. Diaz Perez,N.E. Georgoulia,K. Foroutanpour,Rafał Dziadziuszko

Annals of oncology（2023）

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要